Btk inhibitor ibrutinib reduces inflammatory myeloid cell responses in the lung during murine pneumococcal pneumonia.

de Porto, Alexander P; Liu, Zhe; de Beer, Regina; Florquin, Sandrine; de Boer, Onno J; Hendriks, Rudi W; van der Poll, Tom; de Vos, Alex F.
Mol Med; 25(1): 3, 2019 01 15.
Artigo em Inglês | MEDLINE | ID: mdl-30646846